These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 32345720)

  • 21. Modeling Cystic Fibrosis Using Pluripotent Stem Cell-Derived Human Pancreatic Ductal Epithelial Cells.
    Simsek S; Zhou T; Robinson CL; Tsai SY; Crespo M; Amin S; Lin X; Hon J; Evans T; Chen S
    Stem Cells Transl Med; 2016 May; 5(5):572-9. PubMed ID: 27034411
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transient receptor potential canonical channel 6 links Ca2+ mishandling to cystic fibrosis transmembrane conductance regulator channel dysfunction in cystic fibrosis.
    Antigny F; Norez C; Dannhoffer L; Bertrand J; Raveau D; Corbi P; Jayle C; Becq F; Vandebrouck C
    Am J Respir Cell Mol Biol; 2011 Jan; 44(1):83-90. PubMed ID: 20203293
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genetics of cystic fibrosis: CFTR mutation classifications toward genotype-based CF therapies.
    Fanen P; Wohlhuter-Haddad A; Hinzpeter A
    Int J Biochem Cell Biol; 2014 Jul; 52():94-102. PubMed ID: 24631642
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bicarbonate and functional CFTR channel are required for proper mucin secretion and link cystic fibrosis with its mucus phenotype.
    Gustafsson JK; Ermund A; Ambort D; Johansson ME; Nilsson HE; Thorell K; Hebert H; Sjövall H; Hansson GC
    J Exp Med; 2012 Jul; 209(7):1263-72. PubMed ID: 22711878
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Cystic fibrosis transmembrane conductance regulator (CFTR) gene: mutations and clinical phenotypes].
    Schwartz M
    Ugeskr Laeger; 2003 Feb; 165(9):912-6. PubMed ID: 12661515
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The HDAC inhibitor SAHA does not rescue CFTR membrane expression in Cystic Fibrosis.
    Bergougnoux A; Petit A; Knabe L; Bribes E; Chiron R; De Sario A; Claustres M; Molinari N; Vachier I; Taulan-Cadars M; Bourdin A
    Int J Biochem Cell Biol; 2017 Jul; 88():124-132. PubMed ID: 28478266
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CFTR genotype and clinical outcomes of adult patients carried as cystic fibrosis disease.
    Bonadia LC; de Lima Marson FA; Ribeiro JD; Paschoal IA; Pereira MC; Ribeiro AF; Bertuzzo CS
    Gene; 2014 May; 540(2):183-90. PubMed ID: 24583165
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Personalized medicine in CF: from modulator development to therapy for cystic fibrosis patients with rare CFTR mutations.
    Harutyunyan M; Huang Y; Mun KS; Yang F; Arora K; Naren AP
    Am J Physiol Lung Cell Mol Physiol; 2018 Apr; 314(4):L529-L543. PubMed ID: 29351449
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Residual cftr expression varies with age in cftr(tm1Hgu) cystic fibrosis mice: impact on morphology and physiology.
    Larbig M; Jansen S; Dorsch M; Bernhard W; Bellmann B; Dorin JR; Porteous DJ; Von Der Hardt H; Steinmetz I; Hedrich HJ; Tuemmler B; Tschernig T
    Pathobiology; 2002-2003; 70(2):89-97. PubMed ID: 12476034
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CFTR Deletion Confers Mitochondrial Dysfunction and Disrupts Lipid Homeostasis in Intestinal Epithelial Cells.
    Kleme ML; Sané A; Garofalo C; Seidman E; Brochiero E; Berthiaume Y; Levy E
    Nutrients; 2018 Jun; 10(7):. PubMed ID: 29954133
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacological Correction of Cystic Fibrosis: Molecular Mechanisms at the Plasma Membrane to Augment Mutant CFTR Function.
    Arora K; Naren AP
    Curr Drug Targets; 2016; 17(11):1275-81. PubMed ID: 26648081
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Functional characterization of a novel CFTR mutation P67S identified in a patient with atypical cystic fibrosis.
    Kraus C; Reis A; Naehrlich L; Dötsch J; Korbmacher C; Rauh R
    Cell Physiol Biochem; 2007; 19(5-6):239-48. PubMed ID: 17495464
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Islet-intrinsic effects of CFTR mutation.
    Koivula FNM; McClenaghan NH; Harper AGS; Kelly C
    Diabetologia; 2016 Jul; 59(7):1350-1355. PubMed ID: 27033560
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The phenotypic consequences of CFTR mutations.
    Rowntree RK; Harris A
    Ann Hum Genet; 2003 Sep; 67(Pt 5):471-85. PubMed ID: 12940920
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Unravelling the Regions of Mutant F508del-CFTR More Susceptible to the Action of Four Cystic Fibrosis Correctors.
    Amico G; Brandas C; Moran O; Baroni D
    Int J Mol Sci; 2019 Nov; 20(21):. PubMed ID: 31683989
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cystic fibrosis transmembrane conductance regulator protein (CFTR) expression in the developing human brain: comparative immunohistochemical study between patients with normal and mutated CFTR.
    Marcorelles P; Friocourt G; Uguen A; Ledé F; Férec C; Laquerrière A
    J Histochem Cytochem; 2014 Nov; 62(11):791-801. PubMed ID: 25062999
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Stellate cells are in utero markers of pancreatic disease in cystic fibrosis.
    Leir SH; Tkachenko S; Paranjapye A; Meckler F; Van Wettere AJ; Kerschner JL; Kuznetsov E; Schacht M; Gillurkar P; Regouski M; Viotti Perisse I; Marriott CM; Liu Y; Bunderson I; White KL; Polejaeva IA; Harris A
    Mol Med; 2024 Aug; 30(1):115. PubMed ID: 39112965
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular modelling approaches for cystic fibrosis transmembrane conductance regulator studies.
    Odolczyk N; Zielenkiewicz P
    Int J Biochem Cell Biol; 2014 Jul; 52():39-46. PubMed ID: 24735712
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A novel natural product compound enhances cAMP-regulated chloride conductance of cells expressing CFTR[delta]F508.
    deCarvalho AC; Ndi CP; Tsopmo A; Tane P; Ayafor J; Connolly JD; Teem JL
    Mol Med; 2002 Feb; 8(2):75-87. PubMed ID: 12080183
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Heterogeneous spectrum of mutations in CFTR gene from Indian patients with congenital absence of the vas deferens and their association with cystic fibrosis genetic modifiers.
    Sharma H; Mavuduru RS; Singh SK; Prasad R
    Mol Hum Reprod; 2014 Sep; 20(9):827-35. PubMed ID: 24958810
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.